Llop-Guevara, A., Loibl, S., Villacampa, G., Vladimirova, V., Schneeweiss, A., Karn, T., . . . Serra, V. (2021). Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): Analysis of the GeparSixto randomized clinical trial. Annals of oncology, 32(12), . https://doi.org/10.1016/j.annonc.2021.09.003
Chicago-Zitierstil (17. Ausg.)Llop-Guevara, Alba, et al. "Association of RAD51 with Homologous Recombination Deficiency (HRD) and Clinical Outcomes in Untreated Triple-negative Breast Cancer (TNBC): Analysis of the GeparSixto Randomized Clinical Trial." Annals of Oncology 32, no. 12 (2021). https://doi.org/10.1016/j.annonc.2021.09.003.
MLA-Zitierstil (9. Ausg.)Llop-Guevara, Alba, et al. "Association of RAD51 with Homologous Recombination Deficiency (HRD) and Clinical Outcomes in Untreated Triple-negative Breast Cancer (TNBC): Analysis of the GeparSixto Randomized Clinical Trial." Annals of Oncology, vol. 32, no. 12, 2021, https://doi.org/10.1016/j.annonc.2021.09.003.